Better Outcome With Melatonin Compared to Placebo Administered to Normalize Sleep-wake Cycle and Treat Hypoactive ICU Delirium The Basel BOMP-AID Randomized Trial
Status: Not yet recruiting
Phase of Trial: Phase IV
Latest Information Update: 23 Oct 2019
Price : $35 *
At a glance
- Drugs Melatonin (Primary)
- Indications Delirium
- Focus Therapeutic Use
- Acronyms BOMP-AID
- 18 Oct 2019 Planned number of patients changed from 258 to 190.
- 18 Oct 2019 Planned End Date changed from 31 Mar 2022 to 28 Feb 2022.
- 18 Oct 2019 Planned primary completion date changed from 31 Mar 2021 to 30 Nov 2021.